H.C. Wainwright Remains a Buy on HTG Molecular Diagnostics (HTGM)

In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on HTG Molecular Diagnostics (HTGM – Research Report), with a price target of $8. The company’s shares closed More »

Eiger Biopharmaceuticals (EIGR) Gets a Buy Rating from Ladenburg Thalmann & Co.

Ladenburg Thalmann & Co. analyst Michael Higgins maintained a Buy rating on Eiger Biopharmaceuticals (EIGR – Research Report) today and set a price target of $28. The company’s shares closed yesterday at More »